Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Solid Tumors 1Sarcoma, Alveolar Soft Part 1Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1Muscle-invasive Bladder Cancer 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Etoposide 3Carboplatin 3tremelimumab 2durvalumab 2atezolizumab 2PM 01183 2sacituzumab govitecan 1pembrolizumab 1amrubicin 1Topotecan 1Cisplatin 1AMG 757 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has announcements × Small Cell Lung Carcinoma × atezolizumab × Clear all
NCT05091567 2026-03-10

IMforte

Hoffmann-La Roche

Phase 3 Active not recruiting
660 enrolled 23 charts 1 FDA
Thoracic

Small Cell Lung Carcinoma

NCT02763579 2023-07-28

IMpower133

Hoffmann-La Roche

Phase 3 Completed
503 enrolled 23 charts 1 FDA
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡